| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |